An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia—Study Protocol

An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia—Study Protocol

Invasive meningococcal disease (IMD) causes significant morbidity and mortality worldwide with serogroup B being the predominant serogroup in Australia and other countries for the past few decades. The licensed 4CMenB vaccine is effective in preventing meningococcal B disease. Emerging evidence sugg...

Full description

Bibliographic Details
Main Authors: Helen S. Marshall, Prabha H. Andraweera, James Ward, John Kaldor, Ross Andrews, Kristine Macartney, Peter Richmond, Vicki Krause, Ann Koehler, David Whiley, Lynne Giles, Rosalind Webby, Heather D’Antoine, Jonathan Karnon, Rob Baird, Andrew Lawrence, Helen Petousis-Harris, Philippe De Wals, Belinda Greenwood-Smith, Michael Binks, Lisa Whop
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Vaccines
Subjects:
vaccination
4CMenB
vaccine
meningitis
meningococcal disease
gonorrhoea
Online Access:https://www.mdpi.com/2076-393X/10/2/309

Internet

https://www.mdpi.com/2076-393X/10/2/309

Similar Items